# Biofunctional Testing of a Degradable Implant Made by Mg-Nd and Mg-Zn Alloys Used for Bone Defects

## TL;DR

This paper tests degradable Mg-based implants for bone defects, showing they have good mechanical properties, low corrosion, and are biocompatible.

## Contribution

The study introduces a novel manufacturing route for Mg-Nd and Mg-Zn implants with enhanced corrosion resistance and biocompatibility.

## Key findings

- Mg-Nd and Mg-Zn implants showed mechanical properties similar to human bone.
- Implants had reduced mass loss due to MgF2 conversion coating improving corrosion resistance.
- Biocompatibility was confirmed through cell culture and apoptosis/necrosis analysis.

## Abstract

Regenerative medicine based on Mg alloy implants is considered a modern approach to address bone defects. It represents a promising alternative to traditional grafting strategies (auto-, allo-, and xenografts) by potentially mitigating complications such as donor-site morbidity and limited supply, which are discussed in this paper. In line with this global topic, attention is devoted to an innovative manufacturing route for Mg-Nd and Mg-Zn implants for the treatment of small bone defects. First, the proposed manufacturing method is described in detail, including the materials used and the manufacturing steps, and then a comparison between the reference (cast alloys) and implant samples is performed. The mechanical properties, weight loss in simulated body fluid (SBF), surface analysis (contact angle and roughness measurements), and cytotoxicity were evaluated to determine whether the developed implants are suitable for consideration as future bone implants. The main conclusions of the study were that both Mg-based implants exhibited mechanical properties (compressive strength and Young’s modulus) with values very close to those of the human bone, reduced mass loss (a fact that is in a direct relationship with an increase in corrosion resistance due to MgF2 conversion coating, which is a secondary result of the proposed manufacturing route), and finally, a good biocompatibility sustained by cell culture and cytotoxicity assessment, as well as by apoptosis and necrosis analysis on a human patella-derived osteoblastic cell line.